Quidel Corporation (NASDAQ:QDEL) — Market Cap & Net Worth
Market Cap & Net Worth: Quidel Corporation (QDEL)
Quidel Corporation (NASDAQ:QDEL) has a market capitalization of $1.14 Billion ($1.14 Billion) as of August 3, 2026. Listed on the NASDAQ stock exchange, this USA-based company holds position #8210 globally and #2410 in its home market, demonstrating a 1.15% increase in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying Quidel Corporation's stock price $16.77 by its total outstanding shares 68081767 (68.08 Million). See Quidel Corporation (QDEL) reinvestment ratio to understand how much of operating cash flow is reinvested back into capital assets.
Quidel Corporation Market Cap History: 2015 to 2026
Quidel Corporation's market capitalization history from 2015 to 2026. Data shows change from $1.44 Billion to $1.14 Billion (-0.89% CAGR).
Index Memberships
Quidel Corporation is a constituent of 3 market indices:
| Index | Total Market Cap | Weight (%) | Rank by Market Cap |
|---|---|---|---|
|
NASDAQ Health Care
IXHC
|
$2.46 Trillion | 0.05% | #238 of 976 |
|
NASDAQ Composite
IXIC
|
$40.26 Trillion | 0.00% | #902 of 3165 |
|
S&P Small-Cap 600 Index
SML
|
$1.60 Trillion | 0.15% | #443 of 602 |
Weight: Quidel Corporation's market cap as a percentage of total index value. Rank: Position among all constituents by market cap.
Quidel Corporation Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how Quidel Corporation's valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance.
Latest Price to Sales (P/S) Ratio
0.71x
Quidel Corporation's market cap is 0.71 times its annual revenue
Latest Price to Earnings (P/E) Ratio
N/A
P/E ratio not applicable due to negative or zero earnings
What These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| 2016 | $1.46 Billion | $191.60 Million | -$13.81 Million | 7.61x | N/A |
| 2017 | $2.95 Billion | $277.74 Million | -$8.16 Million | 10.63x | N/A |
| 2018 | $3.32 Billion | $522.28 Million | $74.18 Million | 6.36x | 44.80x |
| 2019 | $5.11 Billion | $534.89 Million | $72.92 Million | 9.55x | 70.05x |
| 2020 | $12.23 Billion | $1.66 Billion | $810.29 Million | 7.36x | 15.09x |
| 2021 | $9.19 Billion | $1.70 Billion | $704.20 Million | 5.41x | 13.05x |
| 2022 | $5.83 Billion | $3.27 Billion | $548.70 Million | 1.79x | 10.63x |
| 2023 | $5.02 Billion | $3.00 Billion | -$10.10 Million | 1.67x | N/A |
| 2024 | $3.03 Billion | $2.78 Billion | -$2.05 Billion | 1.09x | N/A |
| 2025 | $1.94 Billion | $2.73 Billion | -$1.13 Billion | 0.71x | N/A |
Competitor Companies of QDEL by Market Capitalization
Companies near Quidel Corporation in the global market cap rankings as of August 3, 2026.
Key companies related to Quidel Corporation by market ranking:
- Abbott Laboratories (NYSE:ABT): Ranked #114 globally with a market cap of $183.80 Billion USD.
- Stryker Corporation (NYSE:SYK): Ranked #189 globally with a market cap of $124.64 Billion USD.
- Medtronic plc (SA:MDTC34): Ranked #233 globally with a market cap of $104.84 Billion USD ( R$534.32 Billion BRL).
- Medtronic PLC (NYSE:MDT): Ranked #238 globally with a market cap of $103.60 Billion USD.
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #114 | Abbott Laboratories | NYSE:ABT | $183.80 Billion | $105.70 |
| #189 | Stryker Corporation | NYSE:SYK | $124.64 Billion | $325.70 |
| #233 | Medtronic plc | SA:MDTC34 | $104.84 Billion | R$208.39 |
| #238 | Medtronic PLC | NYSE:MDT | $103.60 Billion | $85.39 |
Quidel Corporation Historical Marketcap From 2015 to 2026
Between 2015 and today, Quidel Corporation's market cap moved from $1.44 Billion to $ 1.14 Billion, with a yearly change of -0.89%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2026 | $1.14 Billion | -41.28% |
| 2025 | $1.94 Billion | -35.89% |
| 2024 | $3.03 Billion | -39.55% |
| 2023 | $5.02 Billion | -13.97% |
| 2022 | $5.83 Billion | -36.54% |
| 2021 | $9.19 Billion | -24.86% |
| 2020 | $12.23 Billion | +139.44% |
| 2019 | $5.11 Billion | +53.69% |
| 2018 | $3.32 Billion | +12.62% |
| 2017 | $2.95 Billion | +102.38% |
| 2016 | $1.46 Billion | +1.04% |
| 2015 | $1.44 Billion | -- |
End of Day Market Cap According to Different Sources
On Aug 3rd, 2026 the market cap of Quidel Corporation was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $1.14 Billion USD |
| MoneyControl | $1.14 Billion USD |
| MarketWatch | $1.14 Billion USD |
| marketcap.company | $1.14 Billion USD |
| Reuters | $1.14 Billion USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.
About Quidel Corporation
QuidelOrtho Corporation provides diagnostic testing solutions. The company operates through Labs, Transfusion Medicine, Point of Care, and Molecular Diagnostics business units. The Labs business unit provides clinical chemistry laboratory instruments and tests that measure target chemicals in bodily fluids for the evaluation of health and the clinical management of patients; immunoassay laborator… Read more